Skip to content

Comparison between Remimazolam and Dexmedetomidine in patients undergoing Monitored Anesthesia Care for cataract surgery.

Comparison between Remimazolam and Dexmedetomidine in patients undergoing Monitored Anesthesia Care for cataract surgery. - CRDMAC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000055546
Enrollment
104
Registered
2024-10-19
Start date
2024-09-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract surgery, Monitoreed Anestehsia Care

Interventions

Dexmedetomidine Remimazolam

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients aged 19 years and older scheduled for ophthalmic surgery under MAC ASA class 1.2.3

Exclusion criteria

Exclusion criteria: ASA class 4 or higher Pregnant women Patients with preexisting renal or hepatic dysfunction Patients with severe heart failure or coronary artery disease requiring treatment Patients with known drug hypersensitivity to dexmedetomidine or remimazolam Patients who do not consent to participate in this study Patients with limited ability to understand and complete the study consent form and questionnaires

Design outcomes

Primary

MeasureTime frame
Recovery time after MAC (time required to achieve a PADS score of 9 or higher)

Secondary

MeasureTime frame
Patient Satisfaction and Surgeon Satisfaction Vital Signs: Blood pressure, heart rate, oxygen saturation (during anesthesia, post-anesthesia) Type and Dosage of Medications Used: Anesthetics, vasopressors, others Anesthesia Recovery Record Vital Signs During Anesthesia and Recovery: Blood pressure, heart rate, oxygen saturation Recovery Profile Adverse Effects: Nausea/vomiting, apnea, hypotension, arrhythmia, hypoxemia, conversion of anesthesia method, unplanned hospital admission, use of vasopressors

Countries

Asia(except Japan)

Contacts

Public ContactJiyoun Lee

Seoul National University Bundang Hospital Anesthesia and Pain Medicine

heykiki1@hanmail.net0317873640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026